|
1
|
Mahmoud F and Al-Ozairi E: Inflammatory
cytokines and the risk of cardiovascular complications in type 2
diabetes. Dis Markers. 35:235–241. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Donath MY and Shoelson SE: Type 2 diabetes
as an inflammatory disease. Nat Rev Immunol. 11:98–107. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Eizirik DL, Sammeth M, Bouckenooghe T,
Bottu G, Sisino G, Igoillo-Esteve M, Ortis F, Santin I, Colli ML,
Barthson J, et al: The human pancreatic islet transcriptome:
Expression of candidate genes for type 1 diabetes and the impact of
pro-inflammatory cytokines. PLoS Genet. 8:e10025522012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Turnbaugh PJ, Ley RE, Mahowald MA, Magrini
V, Mardis ER and Gordon JI: An obesity-associated gut microbiome
with increased capacity for energy harvest. Nature. 444:1027–1031.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Pussinen PJ, Havulinna AS, Lehto M,
Sundvall J and Salomaa V: Endotoxemia is associated with an
increased risk of incident diabetes. Diabetes care. 34:392–397.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Landsman D and Bustin M: A signature for
the HMG-1 box DNA-binding proteins. Bioessays. 15:539–546. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lotze MT and Tracey KJ: High-mobility
group box 1 protein (HMGB1): Nuclear weapon in the immune arsenal.
Nat Rev Immunol. 5:331–342. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kim JM, Han HJ, Hur YH, Quan H, Kwak SH,
Choi JI and Bae HB: Stearoyl lysophosphatidylcholine prevents
lipopolysaccharide-induced extracellular release of high mobility
group box-1 through AMP-activated protein kinase activation. Int
Immunopharmacol. 28:540–545. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ghavami S, Rashedi I, Dattilo BM, Eshraghi
M, Chazin WJ, Hashemi M, Wesselborg S, Kerkhoff C and Los M:
S100A8/A9 at low concentration promotes tumor cell growth via RAGE
ligation and MAP kinase-dependent pathway. J Leukoc Biol.
83:1484–1492. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ogawa EN, Ishizaka A, Tasaka S, Koh H,
Ueno H, Amaya F, Ebina M, Yamada S, Funakoshi Y, Soejima J, et al:
Contribution of high-mobility group box-1 to the development of
ventilator-induced lung injury. Am J Respir Crit Care Med.
174:400–407. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang Y, Zhen Y, Wu X, Jiang Q, Li X, Chen
Z, Zhang G and Dong L: Vitexin protects brain against
ischemia/reperfusion injury via modulating mitogen-activated
protein kinase and apoptosis signaling in mice. Phytomedicine.
22:379–384. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Dong L, Fan Y, Shao X and Chen Z: Vitexin
protects against myocardial ischemia/reperfusion injury in
Langendorff-perfused rat hearts by attenuating inflammatory
response and apoptosis. Food Chem Toxicol. 49:3211–3213. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Borghi SM, Carvalho TT, Staurengo-Ferrari
L, Hohmann MS, Pinge-Filho P, Casagrande R and Verri WA Jr: Vitexin
inhibits inflammatory pain in mice by targeting TRPV1, oxidative
stress, and cytokines. J Nat Prod. 76:1141–1149. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Musumeci D, Roviello GN and Montesarchio
D: An overview on HMGB1 inhibitors as potential therapeutic gents
in HMGB1-related pathologies. Pharmacol Ther. 141:347–357. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Abdulahad DA, Westra J, Limburg PC,
Kallenberg CG and Bijl M: HMGB1 in systemic lupus Erythematosus:
Its role in cutaneous lesions development. Autoimmun Rev.
9:661–665. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lin Q, Fang J, Fang D, Li B, Zhou H and Su
SB: Production of recombinant human HMGB1 and anti-HMGB1 rabbit
serum. Int Immunopharmacol. 11:646–651. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Jo EH, Hwang YH and Lee DY: Encapsulation
of pancreatic islet with HMGB1 fragment for attenuating
inflammation. Biomater Res. 19:212015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Andersson U, Wang H, Palmblad K, Aveberger
AC, Bloom O, Erlandsson-Harris H, Janson A, Kokkola R, Zhang M,
Yang H and Tracey KJ: High mobility group 1 protein (HMG-1)
stimulates proinflammatory cytokine synthesis in human monocytes. J
Exp Med. 192:565–570. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Bauernfeind FG, Horvath G, Stutz A,
Alnemri ES, MacDonald K, Speert D, Fernandes-Alnemri T, Wu J, Monks
BG, Fitzgerald KA, et al: Cutting edge: NF-kappaB activating
pattern recognition and cytokine receptors license NLRP3
inflammasome activation by regulating NLRP3 expression. J Immunol.
183:787–791. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Li M, Song L, Gao X, Chang W and Qin X:
Toll-like receptor 4 on islet β cells senses expression changes in
high-mobility group box 1 and contributes to the initiation of type
1 diabetes. Exp Mol Med. 44:260–267. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Shu CJ, Benoist C and Mathis D: The immune
system's involvement in obesity-driven Type 2 diabetes. Semin
Immunol. 24:436–442. 2013. View Article : Google Scholar :
|
|
22
|
Akash MS, Rehman K and Chen S: Role of
inflammatory mechanisms in pathogenesis of type 2 diabetes
mellitus. J Cell Biochem. 114:525–531. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Cai K, Qi D, Hou X, Wang O, Chen J, Deng
B, Qian L, Liu X and Le Y: MCP-1 upregulates amylin expression in
murine pancreatic β cells through ERK/JNK-AP1 and NF-kB related
signaling pathways independent of CCR2. PLoS One. 6:e195592011.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Cui G, Qin X, Zhang Y, Gong Z, Ge B and
Zang YQ: Berberine differentially modulates the activities of ERK,
p38 MAPK, and JNK to suppress Th17 and Th1 T cell differentiation
in type 1 diabetic mice. J Biol Chem. 284:28420–28429. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Aggeli IK, Beis I and Gaitanaki C:
Oxidative stress and calpain inhibition induce alpha B-crystallin
phosphorylation via p38-MAPK and calcium signalling pathways in
H9c2 cells. Cell Signal. 20:1292–1302. 2008. View Article : Google Scholar : PubMed/NCBI
|
